search
for
 About Bioline  All Journals  Testimonials  Membership  News


Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 90, Num. 3, 1995, pp. 425-428
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 90(3): 425-428, may/jun. 1995

Activity of 9-acridanone-hydrazone Drugs Detected at the pre-postural Phase, in the Experimental Schistosomiasis Mansoni

Leogenes Horacio Pereira+ Paulo Marcos Zech Coelho, Jose Oswaldo Costa*, Romulo Teixeira de

Departamento de parasitologia, ICB, Universidade Federal de Minas Gerais, Caixa Postal 486, 30161-970 Belo Horizonte, MG, Brasil ,Departamento de Medicina Veterinaria Preventiva, Escola de Veterinaria, UFMG, Belo Horizonte **Departamento de Analises Clinicas e Toxicol6gicas, Faculdade de Fannacia, UFMG, Belo Horizonte, MG, Brasil

Code Number: OC95083 Size of Files: Text: 16K Graphics: Line Drawings (gif) 5K

The compound Ro-15.5458/000, derivative in the class of 9-acridanone-hydrazones, was found to be effective against Schistosoma mansoni in mice, killing almost all the skin schistosomules (24 hr after infection), when administered at the dose of 100mg/kg. In experintents carried out with Cebus monkeys, the drug was shown to be fully effective at 25mg/kg, 7 days after infection- These data, associated with the good results obtained earlier at the post-postural phase of schistosomiasis, allow the inference that this promising compound may be important in the set of antischistosomal drugs, depending on further toxicological and clinical tests.

Key words: acndanone-hydrazones - Schistosotna mansoni - experimental schistosomiasis

Derivatives in the chemical group of 9-acridanone-hydrazones showed high schistosomicidal activity at the post-postural phase of experimental schistosomiasis in primates (Sturrock et al. 1987, Coelho & Pereira 1991, Coelho et al. 1994 in press). Some compounds of this group, as Ro-lS.5458/000, were found to be highly active against adult worms, at doses of 12.5mg/kg body weight, in Cebus monkeys infected with well defined Brazilian geographical strains of Schistosoma mansoni (Coelho & Pereira 1991, Coelho et al. 1994 in press).

In this study, undertaken to investigate the activity of the compound Ro-15.5458/000 at the pre-postural phase of infection, the authors used albino mice and Cebus monkeys as models.

MATERIALS AND METHODS

The chemical structure of compound Ro15.5458/000, which was developed at the laboratories of F. Hoffmann - La Roche & Co. Ltd. (Basel, Switzerland), is shown in the Figure.

Test with mice - Eighty adult albino mice (Mus musculus), all outbred females, reared at the Schistosomiasis Research Unit - Laboratory Prof. Jose Pellegrino - Federal University of Minas Gerais (Brazil), were used.

    Figure: Chemical structure of the 9-Acfidanone-hydrazone compound used in this work.

The animals were transcutaneously infected with about 100 S. mansoni cercafiae (LE strain), as described by Barbosa et al. (1978). The LE strain of S. mansoni has been maintained at the laboratories of the Schistosomiasis Research Unit for more than 30 years, through Biomphalaria glabrata passages, and using miracidia from the liver of hamsters (Cricetus auratus).

Twenty infected animals were kept as controls, and the other 60 were treated 24hr after infection. The compound Ro-15.5458/000 was given at a dose of 100mg/kg bodyweight, by oral route.

Thirty-five days after infection, the animals were killed by cervical fracture and their portal system was perfused for worms, in general terms, according to the technique described by Pellegrino and Siqueira (1956).

Test with Cebus monkeys - Five adult animals were transcutaneously infected with about 200 S. mansoni cercariae (LE strain). Two monkeys (M-16 and H-17) were maintained as controls, and three others (H-15, H-18 and M-19) received specific treatment (25mg/kg Ro15.5458/000) by oral route, one day after infection (monkey H-15), 7 days after infection (monkey H-18), and 28 days after infection (monkey M-19). Rectal biopsies were carried out at 79 days after treatment, for collection of rectal snips, which were weighed and examined under optical microscope for counting and classification of S. mansoni eggs (quantitative oogram, as outlined by Katz et al. 1966). At 183 days after infection, the monkeys H-15, M-16 and H-18 were sacririced by means of a lethal dose of pentobarbital sodium, and perfused for worms, as described by Pellegrino and Siqueira (1956). Fragments of the liver and intestinal mucosa were examined by using the quantitative oogram method (Katz et al. 1966).

Statistical analysis - The Student's t-test for unpaired samples was used for comparison of the mean numbers of worms recovered from mice.

RESULTS

As can be seen in Table I, a marked difference (p The experiment performed with Cebus monkeys showed partial activity of the drug 24hr after infection, by means of periodic examinations of intestinal mucosal snips (Table II). Moreover, the same experiment clearly showed suppression of egg-laying, when the treatment was started at 7 days after infection.

At 183 days following infection, the monkeys H-18, H-15 and M-16 were sacrificed and peffused for worms.

Monkey H-18 (treated at 7 days after infection) presented no worms at perfusion. The absence of eggs in both hepatic tissue and rectal mucosa confirms the parasitological cure.

At perfusion, monkey H-15 (treated at 24hr after infection) showed the presence of 63 worms (26 females and 37 males), as well as viable eggs in the hepatic tissue and rectal mucosa.

Monkey M-16 (untreated, kept as control) showed a total of 135 worms (86 males and 49 females) at perfusion. This worm recovery, clearly higher than that obtained from monkey H15, suggests a partial activity of the drug, which was able to eliminate some but not all schistosomules at skin level.

DISCUSSION

The results from the present study indicate the efficacy of Ro-15.5458/000 against S. mansoni, at the skin phase, in mice treated with 100mgJkg bodyweight. However, the results obtained from Cebus monkeys treated with this drug, at the dose of 25mg/kg, 24hr after infection (skin phase), were not as satisfactory as those seen in mice, due to the survival of a significant number of worms. On the other hand, at the pulmonary phase of the parasites cycle (7 days after infection), a complete erradication of the parasitism was achieved in Cebus monkeys. These latest results showed the full effectiveness of the drug Ro-15.5458/000 given at a relatively lower dose (25mgJkg), at the pulmonary phase. Possibly, using higher doses in Cebus monkeys, the parasite's population could be markedly reduced at the skin phase (24hf after infection).

TABLE I

Recovery of worms from mice, by means of peffusion of the portal system, 35 days after trapscutaneous infection with about 200 Schistosoma mansoni cercanae, from the group treated with Ro-15.5458/000 (100mg/kg), at 24hr after infection, and the respective control group

with Ro- 15.5458/000a 100mg/kg)
No. of mice - 60

Male Total = 3
M+/- SD = 0.05+/-0.22

Female Total= 7
M+/-SD = 0.12+/-0.32

Total worms Total = 10
M+/- SD = 0.17+/-0.37

                 male                female       Total worms
Control        Total= 393          Total = 158    Total = 551
No. of mice=16   M+/-SD=23.94+/-7.87 M+/-SD=9.87+/-4.27 M-/+SD 
                                                =34.44+/-9.63

a: 10 out of 60 treated mice were found to be positive (1 worm/per animal)

The Student's t-test showed highly significant differences for all the values from the treated group in relation to the respective values from the control group (p<0.001).

TABLE II

Activity of Ro-15.5458/000 (25mg/kg, per os, single dose) in prepostural periods of infection by Schistosoma mansoni (LE strain) in Cebus monkeys. Each primate was previously exposed to about 200 cercariae

-------------------------------------------------------------
         Time of                    Oogram (viable eggs)   
         treatment   Days   ----------------------------------

Monkey   (days after after   1st    2nd   3rd   4th  mature    
         infection)  treatment                               
--------------------------------------------------------------
H-15                  79      14     0    0      1      3
                      100     0      0    0      0      0 
         1 day        130     0      0    4      0      1   
                      142     8      3    8      3      7
                      163     0      0    0      2      6
                      186     0      0    0      0      2 

H-18                  79      0      0    0      0      0
                      100     0      0    0      0      0
         7days        130     0      0    0      0      0
                      142     0      0    0      0      0
                      163     0      0    0      0      0
                      186     0      0    0      0      0

M-19                  59      46     56   135    71     156   

                      72      26     4    31     11     45   
         28 days      87      1      0    0      13     3
                      117     0      0    5      2      18
                      126     8      5    12     15     59
                      147     0      1    2      68     175 
                      158     19     1    4      1      11

M-16       no         87      0      0    0      0      0  
control    drug       101     9      5    2      0      0
monkey     used       131     1      6    30     10     1 
                      143     17     31   2      0      18   
                      164     9      29   50     15     30   
                      178     0      0    0      0      4

H-17       no         87      0      5    5      0      30
control    drug       101     5      20   31     16     25
monkey     used       131     3      0    2      0      51 
                      143     0      3    0      5      80
                      164     25     12   5      28     36 
                      178     8      9    5      20     47 
-------------------------------------------------------------
-------------------------------------------------------------
         Time of                            No.
         treatment   Days                   viable eggs
Monkey   (days after after         Dead     per gramm of 
         infection)  treatment     eggs     rectal snips       

--------------------------------------------------------------
H-15                  79            47         269 
                      100           10         0 
           1 day      130           5          147 
                      142           7          617 
                      163           13         267 
                      186           5          55
H-18                  79            0          0 
                      100           0          0 
           7days      130           0          0 
                      142           0          0 
                      163           0          0 
                      186           0          0
M-19                  59            336        9098 
                      72            335        2127 
           28 days    87            17         370 
                      117           68         781 
                      126           84         2813 
                      147           28         6482 
                      158           14         1091
M-16       no         87            83         0 
control    drug       101           22         400 
monkey     used       131           22         1379 
                      143           116        2267 
                      164           48         3325 
                      178           8          103
H-17       no         87            28         755 
control    drug       101           47         2694 
monkey     used       131           77         1041 
                      143           85         2009 
                      164           31         3365 
                      178           45         2713
-------------------------------------------------------------

Another experiment was devised to investigate this point of interest, but difficulties in getting Cebus monkeys prevent us to carry out a subsequent study.

Earlier results obtained with 9-acridanonehydrazones showed the efficacy of these drugs at the post-postural phase of schistosomiasis mansoni (Stunock et al. 1987, Coelho & Pereira 1991, Coelho et al. 1994 in press). The results re- corded so far, added to the ones presented in this compounds may be considered as an impotlant reserve in the set of schistosomicide drugs. The 9-acridanone-hydrazone compounds, if approved by means of toxicological and clinical tests, may play an important role in the treatment for human schistosomiasis.

ACKNOWLEDGMENTS

To Dr HR Stohler (F Hoffmann-La Roche & Co. Ltd, Basel, Switzedand) for providing compounds used in work, as well as for financial support and advice; to Dr Faical Simon and Dr Adayr Mafuz Saliba (Fundacao Parque Zoologico de Sao Paulo) for the supply de Paula Ribeiro for translating the manuscript; to Mr Alberto G Santos, Mrs Alice Neni F Balzuweit, Miss Zenir de Souza, and in memoriam: Mr Adelino Ferreim and Mr Mauncio V Costa, for technical assistance.

REFERENCES

Barbosa MA, Pellegrino J, Codho PMZ, Sampaio IBM 1978. Quantitative aspects of the migration and evolutive asynchronism of Schistosoma mansoni in mice. Rev Inst Med Trop S Paulo 20: 121-132.

Codho PMZ, Pereira LH 1991. Schistosoma mansoni: Preclinical studies with 9-Acridanone-hydrazones in Cebus monkeys experimentally infected. Rev Inst Med Trop S Paulo 33: 50-5Z

Coelho PMZ, Pereira LH 1994. Antischistosomal activity of 9-Acridanone-hydrazones in Cebus monkeys experimentally infected with the SJ strain of Schistosoma mansoni. Rev Inst Med Trop S Paulo (in press).

Katz N, Pellegrino J, Pompeu-Memoria JIM 1966. Quantitative oogram method in Cebus monkeys ex- perimentally infected with Schistosoma mansoni. J Parasitol 52: 917-919.

Pellegrino J, Siqueira AF 1956. Tecnica de peffusao pain colbeita de Schistosoma mansoni em cobaias experimentalmente infestadas. Rev Bras Malariol 8: 589-597.

Sturrock RF, Bain J, Webbe G, Doenhoff MJ, Stohler H 1987. Parasitological evaluation of curative and subeumtive doses of 9-Acndanone-hydrazone drugs against Schistosoma mansoni in baboons, and observations in senan levels of anti-egg antibodies detected by ELISA. Trans R Soc Trop Med Hyg 81: 188-192.

Copyright 1995 Fundacao Oswaldo Cruz


The following images related to this document are available:

Line drawing images

[oc95083a.gif]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil